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A Chronic Contact Eczema Impedes Migration
of Antigen-Presenting Cells in Alopecia Areata
Pooja Gupta1, Pia Freyschmidt-Paul2, Mario Vitacolonna1, Sabine Kiessling2, Susanne Hummel1,
Dagmar Hildebrand1, Rachid Marhaba1 and Margot Zo¨ller1,3
Long-lasting allergen treatment is the most efficient therapy in alopecia areata (AA). The underlying mechanism
is unknown. We here asked whether treatment with a contact sensitizer influences leukocyte migration such
that dendritic cell (DC) migration or the recruitment of activated T-cells towards the skin become hampered.
Allergen treatment of AA mice was not accompanied by a decrease in skin-infiltrating leukocytes or draining
lymph node cells (LNC). However, the distribution of leukocyte subsets was changed with a dominance of
monocytes in the skin and a reduced percentage of DCs in draining nodes. Chemokine and chemokine
receptor expression in skin and draining nodes was strikingly increased and LNC from untreated and allergen-
treated AA mice showed high migratory activity in vitro and readily homed in draining nodes and skin after
intravenous injection. However, FITC labelling of the skin and subcutaneous transfer of dye-labelled DC
revealed that allergen treatment created a chemokine milieu severely hampering DC migration from the skin
towards the draining node. An allergic eczema-induced reduction in DC migration and antigen transfer could
well contribute to insufficient T-cell activation and the recovery of hair follicle in AA and possibly be of
relevance for other skin-related autoimmune diseases.
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INTRODUCTION
Alopecia areata (AA) is an autoimmune disease of the skin
that affects anagen stage hair follicles (Ito et al., 2004). The
human disease is closely mimicked by C3H/HeJ mice, that
spontaneoulsy or after the transfer of full thickness skin grafts
from AA-affected mice develop AA (McElwee et al., 1998,
2003a, b). Although the effector cells are CD8þ CTL (Gilhar
et al., 2002; McElwee et al., 2003a, b), there is obviously
a major contribution of Th as revealed by the highly
efficient transfer of AA via CD4þ T-cells from AA-affected
mice (Gilhar et al., 2002; McElwee et al., 2005).
The most efficient therapy of AA relies on induction of a
chronic delayed-type hypersensitivity reaction via local
application of a contact sensitizer (Freyschmidt-Paul et al.,
2003; McMichael and Henderson, 2004; Dall’oglio et al.,
2005). The topical application of the contact sensitizer is
refreshed for several months such that a mild form of a
chronic eczema is persistently maintained. Hair regrowth in
humans is observed in 50–70% of patients with therapeutic
success becoming apparent after 8–26 weeks (Freyschmidt-
Paul et al., 2003). In the mouse model, complete hair
regrowth is observed in 100% of mice after 6–10 weeks of
squaric acid dibutyl ester (SADBE) treatment (Zo¨ller et al.,
2004).
The therapeutic efficacy of a chronic delayed-type
hypersensitivity reaction in autoimmune disease does not
appear trivial. We reported recently on a slightly reduced
effector T-cells recruitment towards the skin (Zo¨ller et al.,
2004), which could have been due to induction of a mild
fibrosis by the prolonged maintenance of a delayed-type
hypersensitivity reactions. It also could have been provoked
by the recovery of regulatory T-cells, or by altered cyto-
kine and chemokine secretion with the consequence of,
for example a preferential recruitment of monocytes and/or
hapten-specific Th cells in response to SADBE and a lack
of AA-specific Th or CTL recruitment. To answer these
questions, we here explored leukocyte migration in untreated
and SADBE-treated AA-affected mice.
There has been a recent explosion in knowledge on
chemokines and their receptors in guiding and regulating the
traffic, homing and recruitment of naive and activated leuko-
cytes (Campbell et al., 2003; Moser et al., 2004; Sallusto and
Mackay, 2004). The skin, as a major barrier between the
body and the external environment has attracted particular
attention (Hwang, 2001; Homey, 2004). These studies revea-
led that chemokine and chemokine receptor expression
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changes dramatically during activation of an immune
response.
Activated keratinocytes increase secretion of CXCL8 (IL8),
CCL27 (CTACK), and CXCL12 (SDF1), chemokines that
promote T-cell homing and produce, in addition, CXCL11
(I-TAC), CCL1 (I309), CCL5 (Rantes), CCL20 (MIP3a), CCL22
(MDC), and most abundantly CXCL10 (IP10), CCL2 (MCP1)
and CXCL8 (Morales et al., 1999; Vestergaard et al., 2000;
Albanesi et al., 2001). Dermal fibroblasts and activated
endothelial cells contribute to T-cell recruitment by secretion
of a large array of cytokines (Dieu-Nosjean et al., 2000; von
Andrian and Mackay, 2000; Dulkys et al., 2001). An
additional, abundant source of chemokines are infiltrating
monocytes and dendritic cell (DC), which secrete CCL3
(MIP1a), CCL4 (MPI-1b), CCL5, CCL2, CXCL8, and later
during response CCL17 (TARC), CCL22, CCL18 (PARC), and
CCL19 (ELC) (Sallusto et al., 1999; Allavena et al., 2000;
Vissers et al., 2001). An amplification loop is created by skin
infiltrating T-cells that secrete IL4, interferon (IFN)g, and
tumor necrosis factor (TNF)a, most potent cytokines for
chemokine induction (Dieu-Nosjean et al., 2000; Albanesi
et al., 2000, 2001). Activated, skin seeking T-cells down-
regulate their receptors for inflammatory chemokines except
for CCR4, CCR8 and CCR6 and become stationary (Sallusto
and Mackay, 2004).
DC, too, change their chemokine/chemokine receptor
expression profile most dramatically during activation
(Cyster, 2005; Randolph et al., 2005a, b, Sozzani, 2005;
Yoneyama et al., 2005). Myeloid DC migrate in response to a
wide array of inflammatory chemokines (Vermi et al., 2005),
leave the circulation and enter the tissue including the
dermis. While circulating DC precursors express CCR2 and
CXCR4, immature tissue DC are characterized by high
expression of CCR1, CCR2, CCR5, CCR6, CXCR1, CXCR2,
and CXCR4, which bind to CCL2, CCL3, CCL4, CCL5,
CCL20, and CXCL12 (Cavanagh and von Andrian, 2002).
During maturation/activation DC downregulate these recep-
tors (Sallusto et al., 1998; Sozzani, 2005) and upregu-
late CCR7, which guides them to CCL21 on lymphatic
endothelial cells to leave the skin via the lymphatics
and enter the draining lymph node in the afferent lymph
(Gunn, 2003; Randolph et al., 2005a, b). Besides CCR7,
CCR8 and its ligand CCL1 may also be involved (Qu et al.,
2004). Within the lymph node, DC attract naive T-cells via
CCL19 and CCL18) (Vulcano et al., 2001) and during
activation via CCL17 and CCL22, that bind CCR4 on recently
activated T-cells (Vulcano et al., 2001; Qu et al., 2004).
Distinct to T-cells, activated DC are supposed not to leave
the lymph node and re-enter the circulation (Kamath et al.,
2002).
While there is abundant information on chemokine
and chemokine receptor expression in allergic contact hyper-
sensitivity (reviewed by Goebeler et al., 2001), not much
is known about AA. CXCL10 is expressed by follicular
epithelium (Gilhar et al., 2003). In addition, mononuclear
cells and keratinocytes strongly express CXCL9, moderately
CCL2, and weakly CXCL10 (Benoit et al., 2003; Simonetti
et al., 2004).
Taken together there are distinct and opposing require-
ments for homing of DC into the skin, the leave of DC after
antigen contact and the optimal environment supporting
T-cell and monocyte recruitment. Thus, we hypothesized that
the therapeutic efficacy of a chonic eczema in AA-affected
individuals may be the consequence of a disturbed chemo-
kine balance that somehow interferes with effector T-cell
homing into AA-affected skin.
RESULTS
AA-affected patients and mice are most efficiently treated
with allergic contact sensitizers (Freyschmidt-Paul et al.,
2003). We recently reported that SADBE treatment may be
accompanied by altered leukocyte migration (Zo¨ller et al.,
2004). To sustain the hypothesis we explored chemokine
expression in the skin of SADBE-treated AA mice and
evaluated whether T-cell extravasation into the skin or DC
migration towards the draining lymph node may be altered
in mice with a mild chronic eczema.
SADBE-induced changes in adhesion molecule and chemokine
expression
As already reported, SADBE treatment is not accompanied
by a reduction in skin-infiltrating leukocytes (SkIL) or draining
lymph node cells (LNC) as compared to AA-affected
mice. The number of SkIL and draining LNC is significantly
increased in untreated and SADBE-treated AA mice as
compared to healthy controls. The number of draining LNC
and SkIL also increases during SADBE treatment. However, it
does not reach the level observed in AA and SADBE-treated,
AA-affected mice (AA/SADBE mice) (Figure 1).
The distribution of leukocyte subpopulations in draining
LNC and SkIL revealed an increase in CD4þ LNC and an
increase in CD8þ SkIL in AA mice. In allergen-treated AA
mice, CD4þ cells were not increased. The main feature in
SADBE-treated mice was an increase in the percentage of
monocytes in SkIL. In SADBE-treated AA mice, too, the
percentage of CD11bþ cells was increased in SkIL, but was
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Figure 1. Allergen treatment has no impact on the high recovery of LNC and
SkIL of AA mice. The number of draining LNC and SkIL (mean7SD) is shown
for control, AA-, SADBE-treated, and AA/SADBE mice. Values are derived
from eight experiments, each with a pool of leukocytes from three mice.
Significant differences in comparison to control mice are indicated by an
asterisk.
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reduced in draining LNC. Similarly, two DC-specific anti-
bodies stained a higher percentage of SkIL in SADBE and
AA/SADBE than in control and AA mice, but stained less LNC
in AA/SADBE than in AA mice (Figure 2a and b). This could
have been a first indication for differences in the migration of
antigen-presenting cells (APC) from AA/SADBE as compared
to AA mice.
To consolidate the assumption, draining LNC and SkIL
were stained with additional monocyte/macrophages (Mf)
and DC markers. Staining for the monocyte and Mf marker
CD51 and CD61 and for CD105, an endothelial cell marker
also expressed by activated Mf, revealed that CD51 and
particularly CD61 were strongly expressed in SADBE and AA/
SADBE SkIL. Expression was not increased in draining LNC
of AA/SADBE mice. CD105 expression was only increased
in SkIL of SADBE-treated mice. Notably, CD44v10, that
is preferentially expressed by monocytes, also revealed
high expression in SADBE and AA/SADBE SkIL, but reduced
expression in LNC of AA/SADBE as compared to AA mice
(Figure 2c and d).
Finally, CD44 expression, known as an activation marker
contributing to leukocyte extravasation, was high in draining
LNC of AA, SADBE, and AA/SADBE mice and in SkIL
of SADBE mice. CD54 and CD102 revealed similar expres-
sion profiles. CD11a behaved exceptional inasmuch as its
expression was reduced in draining LNC and SkIL of AA mice
(Figure 2e and f). Staining of SkIL with anti-CD18 and
-CD49d did not reveal significant difference between
AA/SADBE and AA mice (data not shown). Besides these
differences in the relative percentage of subpopulations
in SkIL of the four groups of mice, it should be remembered,
as outlined in Figure 1 and demonstrated in Figure 2g that
leukocyte infiltrates were strongly increased in AA, SADBE-
treated, and AA/SADBE mice.
Taken together, SADBE treatment induced a slight reduc-
tion in CD4þ LNC and SkIL and a strong reduction in
monocytes and DC in LNC of AA mice, but had no effect
on adhesion molecule expression on activated T-cells.
To explore, whether the reduced recovery of APC in the
draining node could be due to SADBE-induced changes in
leukocyte migration, we evaluated the chemokine expres-
sion profile in draining LNC, SkIL, and the dermis as well as
expression of IL4, TNFa and IFNg, cytokines known as potent
chemokine inducers.
Expression of all three cytokines was high in LNC and
SkIL of AA mice and did not become reduced in SADBE-
treated AA mice, rather TNFa expression in SkIL was even
augmented by SADBE treatment (Figure 3).
According to the cytokine expression profile one would
not have expected a reduction in chemokine expression in
AA mice by allergen treatment. In fact, chemokine expression
in draining LNC of AA, SADBE, and AA/SADBE mice
was significantly increased as compared to control mice.
This accounted for CCL2, CCL5, and osteopontin (OPN),
which support leukocyte recruitment in general, and for
CXCL10 recruiting in particular activated T-cells. Expression
of the monocyte recruiting chemokine CCL1 was upregulated
only in LNC of allergen-treated mice. Instead, allergen
treatment was accompanied by a reduction in the T-cell-
recruiting chemokine CCL17 and in CCL20, that supports DC
and naive T-cell migration into the draining lymph node.
Notably, the reduction in CCL17 and CCL20 expression was
also seen in SkIL and the dermis of SADBE-treated AA mice.
Expression of the chemokine receptors CCR4, CCR6 and
CCR8 was increased as compared to control mice. It did not
differ significantly between LNC of untreated and SADBE-
treated AA mice. In SkIL and the dermis, expression of CCR6,
the ligand of CCL20 was slightly reduced in SADBE-treated
as compared to untreated AA mice (Figure 4a–c).
Thus, CCL1 and CCR8 expression was at an equal or
increased level in AA/SADBE as compared to AA mice, which
argues against a reduction in monocyte recruitment towards
the skin. CCL17 expression was slightly reduced in AA/
SADBE mice, but CCR4 expression was unaltered, the latter
arguing against a serious defect in T-cell recruitment. How-
ever, CCL20 expression was only upregulated in AA mice,
which could have been indicative for a reduction in recruit-
ing naive T-cells or DC towards the draining lymph node
in SADBE-treated AA mice. To substantiate our hypothesis
that activated T-cell recruitment towards the skin may not be
impaired, but that APC migration may be affected by SADBE
treatment, leukocyte migration was evaluated in vitro and
in vivo.
Allergen treatment does not affect activated T-cell migration/
extravasation of AA mice
Freshly harvested LNC from AA and AA/SADBE mice
displayed the highest migratory activity in vitro, independent
of any stimulus. Instead, migration of LNC of SADBE-treated
mice exceeded the one of control mice only in response to
OPN and CXCL10. In all, four groups of mice, the response
towards OPN exceeded the response to CXCL10. Thus, LNC
of AA mice displayed high migratory activity and there was
no evidence for a negative interference by SADBE treatment
(Figure 5).
To explore, whether T-cell migration in vivo is impaired
in AA/SADBE mice, dye-labelled LNC from control, AA-, or
SADBE-treated mice were injected i.v. into donor corres-
ponding or AA/SADBE mice. After 3 days the percentage of
stained LNC and SkIL was evaluated. When AA/SADBE mice
received an i.v. injection of dye-labelled LNC from control,
AA, or SADBE mice, the percentage of dye-labelled cells
recovered from the draining lymph node and the skin was
not significantly reduced as compared to SADBE-treated
mice and was even increased as compared to AA mice. There
was also no evidence that LNC from healthy mice home
less efficiently in AA/SADBE than in healthy mice. Instead,
the percentage of labelled LNC recovered in AA/SADBE mice
apparently is reduced because AA/SADBE mice contain
significantly more LNC and SkIL than healthy controls (Figure
6a and b). These findings rather excluded hindrance of T-cell
migration by SADBE treatment, but indicated that the host has
some impact on leukocyte homing into the skin.
The hypothesis was confirmed by evaluating the recovery
of dye-labelled subpopulations. As demonstrated for CD4þ
cells, no significant differences were observed when evaluat-
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Figure 2. The impact of allergen treatment on the distribution of leukocyte subpopulations in draining lymph nodes and skin. (a, b, and g) The main leukocyte
subpopulations, (c and d) monocytic subpopulations, and (e and f) common leukocyte subpopulations were evaluated in draining LNC and SkIL of control,
AA-, SADBE-treated, and AA/SADBE mice by (a–f) flow cytometry and (g) immunohistology of 5mm sections of shock-frozen skin, which were counterstained
by hematoxilin (bar¼ 50mm). (a–f) The percentage (mean7SD of five experiments) of stained cells is shown. Significant differences to LNC and SkIL of control
mice are indicated by an asterisk.
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ing the homing of dye-labelled LNC into lymph nodes of
control, AA, SADBE, or AA/SADBE mice. Considering the
percentage of dye-labelled markerþ SkIL, it became obvious
that LNC from AA and particularly from SADBE-treated mice
homed more readily than LNC from control mice into the skin.
This is well in line with the increase in chemokine expression
in the skin of AA- and SADBE-treated mice. Furthermore,
SADBE treatment of AA mice had no negative impact on skin
homing of LNC from either AA- or SADBE-treated mice. Thus,
the high skin-homing potential of LNC subpopulations from
AA mice was preserved or even increased in AA/SADBE mice
(Figure 6c and d). This accounted also for CCR4þ , CCR6þ ,
and CCR8þ LNC from AA and SADBE mice, which homed
most efficiently into the skin of AA/SADBE mice (Figure 6e).
Thus, the chemokine milieu in the skin of AA/SADBE mice
supported leukocyte skin homing.
Taken together, the curative effect of a chronic contact
eczema in AA-affected individuals is unlikely due to a
hindrance of effector cell migration towards their target in the
skin. Thus, we next asked, whether SADBE treatment has an
impact on T-cell or APC migration from the skin towards the
draining lymph node.
SADBE treatment of AA mice interferes with DC recruitment
into the draining node
To control for the recruitment of leukocytes from the skin
towards the draining node, FITC was topically applied on the
shaved skin. Three days thereafter, mice were sacrificed and
the percentage of stained leukocytes in SkIL and draining
lymph nodes was evaluated. SkIL of control mice were
less efficiently stained than those of AA-, SADBE-treated, and
AA/SADBE mice and accordingly, less dye-labelled cells
were recovered in draining lymph nodes of control mice.
However, the overall percentage of stained SkIL and draining
LNC did not differ significantly between the latter three
groups of mice (Figure 7a and b).
This was different when evaluating the percentage of
dye-labelled subpopulations, where emphasis was given to
differences between AA- versus SADBE-treated or AA/SADBE
rather than control mice. First to note, as compared to AA
mice, SkIL of SADBE-treated and AA/SADBE mice contained
a significantly increased percentage of FITC-labelled CD11bþ
and CD11cþ leukocytes. Instead, in draining nodes, the
percentage of FITC-labelled CD11bþ and CD11cþ and
of DC marker stained cells was reduced as compared to
AA mice. Calculating the ratio of dye-labelled LNC to
SkIL, provided further evidence, that a reduced percentage
of monocytes (CD11bþ , CD44v10þ ) and CD11cþ /DC-
markerþ cells migrated from the skin of SADBE-treated and
AA/SADBE mice towards the draining node. Thus, APC
migration was impaired in mice with a chronic delayed-type
hypersensitivity reaction, which feature became dominating
in allergen-treated AA mice (Figure 8a–d).
Evaluating CCL1/CCR8 (monocyte recruitment), CCL17/
CCR4 (T-cells recruitment), CXCL10 (activated T-cells recruit-
ment) and CCL20/CCR6 (DC and CD4 recruitment towards
lymph node follicles), it became obvious that the percentage
of FITC-labelled chemokine- and chemokine receptor-
positive SkIL was increased in AA, SADBE-treated and AA/
SADBE compared to healthy mice. Major differences bet-
ween SkIL from AA versus SADBE-treated and AA/SADBE
mice were observed with respect to CCL17, CCL20, CCR4,
CCR8, and CCR6, where a significantly higher percentage of
FITC-labelled cells was recovered in SkIL of SADBE-treated
and AA/SADBE than of AA mice. Instead, in draining lymph
nodes, recovery of dye-labelled cells expressing these
markers was decreased in SADBE-treated and AA/SADBE
as compared to AA mice. Accordingly, the ratio between
dye-labelled CCL17þ , CCL20þ , CCR4þ , CCR6þ , and
CCR8þ LNC versus SkIL was lower in SADBE-treated and
AA/SADBE mice than in AA mice (Figure 8e–h). Migration
of labelled CXCL10þ (Figure 8f–h), CCL2þ , CCL5þ , and
OPNþ (data not shown) SkIL towards the draining lymph
node was increased in AA, SADBE-treated and AA/SADBE
compared to healthy mice and there was no evidence for
impaired migration by allergen treatment.
Taken together, although chemokine and chemokine
receptor-expressing cells mostly migrate more efficiently
from the skin towards the draining lymph node in AA and/
or allergen-treated compared to healthy controls, migration
of CCL17þ , CCR4þ , and CCR8þ SkIL was less effective in
SADBE-treated than in AA mice, where SADBE treatment
dominated the migratory capacity of SkIL in AA/SADBE mice.
The finding is in line with the reduced recovery of monocytes
in the draining nodes of SADBE-treated mice. Impaired
migration of CCL20þ and CCR6þ SkIL of SADBE-treated and
AA/SADBE compared to AA mice corresponds to the reduced
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Figure 3. Cytokine expression in LNC and SkIL of untreated and
allergen-treated AA mice. (a and b) Cytokine expression was evaluated
by intracellular staining and flow cytometric analysis in fixed and
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recovery of APC in draining nodes of SABE-treated and AA/
SADBE mice.
To see whether particularly DC migration becomes altered
by allergen treatment of AA mice and whether it is the DC
itself or the environment, a mixture of dye-labelled DC
and Mf from AA- or SADBE-treated mice was injected
subcutaneously in AA-, SADBE-treated, or AA/SADBE mice.
Should the host environment be decisive, differences would
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Figure 4. Chemokine profile of LNC, SkIL and the dermis of untreated and allergen-treated AA mice. (a and b) LNC and SkIL of control, AA, SADBE, and AA/
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be mainly expected with respect to the recovery of DC in the
draining lymph node of AA/SADBE as compared to AA- or
SADBE-treated mice, irrespective of whether the DC/Mf
derived from AA- or SADBE-treated mice. Should the DC/Mf
population be decisive, recovery of cells in the draining
lymph node should differ depending on whether the cells
were derived from AA- or SADBE-treated mice. The overall
recovery of dye-labelled cells in the draining lymph node was
low, which hampered the evaluation of significant differ-
ences in the percentage of recovered cells (data not shown).
However, when measuring the percentage of dye-labelled
DC and Mf it became obvious that both the host environ-
ment and the donor are important for the migratory activity of
subcutaneously applied APC. Thus, a relatively high percen-
tage of dye-labelled Mf/DC was consistently retained in the
dermis of allergen-treated AA mice, irrespective of whether
the cells derived from AA or SADBE-treated mice. However,
retention in the skin did not differ significantly between AA/
SADBE and SADBE-treated mice. Most impressive was the
poor recovery of dye-labelled DC in the draining node of
SADBE-treated and AA/SADBE mice. This accounted parti-
cularly for CD44v10þ and CD11cþ cells (Figure 9a–c). Thus,
migration of APC from the skin towards the draining lymph
node is high in AA, but impaired in repeatedly SADBE-treated
mice.
Taken together, T-cells of AA mice display very strong
migratory activity and this is not hampered by a chronic
allergic eczema. Instead, DC migration from the skin towards
the draining lymph node becomes severely impaired by
repeated allergen treatment.
DISCUSSION
We here explored in AA mice that had been treated with
SADBE for a short time, whether alterations in leukocyte
traffic might contribute to the therapeutic efficacy of a
chronic allergic eczema (Freyschmidt-Paul et al., 2003;
McMichael and Henderson, 2004; Dall’oglio et al., 2005;
Ujiie et al., 2005). Although there was evidence that
leukocyte traffic may be hampered in long-term SADBE-
treated mice, possibly due to a mild fibrosis (Zo¨ller et al.,
2004), we expected that during the ongoing ‘‘healing
process’’ changes between untreated and allergen-treated
AA mice might be most pronounced. In fact, leukocyte migra-
tion becomes severely altered. However, different to our
expectation, it has not been the extravasation of activated
leukocytes, but the migration of APC from the skin towards
the draining node that was impaired in allergen-treated
mice.
Adhesion molecule and chemokine expression differs in skin
and draining nodes of untreated versus allergen-treated AA
mice
AA mice displayed a relative increase in CD4þ LNC and
SkIL and a relative increase in CD8þ SkIL. In SkIL of SADBE
mice CD11b, CD11c, and a DC-marker, as well as additional
monocyte markers, CD44v10, CD51, CD61, and CD105
were upregulated. This also accounted for the common
leukocyte markers panCD44, CD54, CD102, and CD11a,
all known to contribute to leukocyte migration. With respect
to the latter, AA mice displayed upregulated CD54 and
CD102 expression only in draining LNC. It also should
be noted that CD11a was decreased in LNC and SkIL of
AA mice. The mechanism underlying the downregulation of
CD11a has not yet been clarified. The leukocyte marker
expression profile of AA/SADBE mice mostly resembled the
one of SADBE mice. However, the percentage of CD11bþ ,
CD11cþ , and DC-markerþ LNC was decreased as compared
to AA mice, providing a first evidence that APC migration
differs in allergen-treated and untreated AA mice.
The most potent mediators of leukocyte migration are
chemokines and their receptors. Chemokine and chemokine
receptor expression was strikingly upregulated in draining
LNC, SkIL and the dermis of SADBE-treated, AA/SADBE and,
though less impressive, AA mice. This also accounted for
the chemokine inducers IL4, TNFa, and IFNg (Dieu-Nosjean
et al., 2000; Albanesi et al., 2001; Nakayama et al., 2001).
However, AA-, SADBE-treated, and AA/SADBE mice differed
in some respects: Firstly, high-level CCL1 expression was
mainly seen in SADBE-treated mice, which corresponds to
the high-level IFNg expression, known as CCL1 inducer
(Albanesi et al., 2000; Campbell et al., 2003); Secondly,
CCL5 and CXCL10 expression appeared more pronounced
in the dermis of SADBE-treated than -untreated AA mice,
which finding is in line with the increased recovery of Mf
and DC in SkIL of allergen-treated mice and could be pro-
voked by the increased level of TNFa and IFNg. An ampli-
fication loop could be created by activated Mf and DC, that
secrete CCL5 and CXCL10 (Allavena et al., 2000; Vissers
et al., 2001; Blackwell and Krieg, 2003). Similar to AA
patients (Benoit et al., 2003) CXCL10 expression was weak in
untreated AA mice. Thus, one could speculate that allergen
treatment might support the recruitment of effector T-cells;
However, importantly, CCL17 and CCL20 expression was
reduced in allergen-treated AA mice. These chemokines
become upregulated in APC during activation and also serve
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as attractant for DC and T-cells to enter the draining node
(Vulcano et al., 2001).
Taken together, (i) obvioulsy high-level CCL17 and CCL20
expression is required to sustain antigen presentation
and effector T-cell activation even in ‘‘steady state’’ AA;
(ii) The striking induction of chemokines and their receptors
by the repeated application of a contact sensitizer rather
excludes that a chronic contact eczema interferes with
effector cell extravasation; (iii) Even though we do not yet
know why CCL17 and CCL20 expression are not supported
by allergen treatment, this feature points towards the possi-
bility of an impaired DC recruitment in allergen-treated AA
mice.
A contact eczema does not affect effector cell extravasation
towards the skin in autoimmune mice
Activated T-cell recruitment towards the skin is facilitated
by CCR4, CCR6 CCR8, and CCR10 expression, the chemo-
kine receptors being attracted by CCL17, CCL1, CCL20, and
CCL27, respectively (Fitzhugh et al., 2000; Homey et al.,
2000; Vestergaard et al., 2000). Taking into account high-
level CCR4, CCR6, and CCR8 expression in draining LNC of
allergen-treated AA mice, impaired skin homing appeared
unlikely. On the other hand, the reduced recovery of SkIL in
long-term SADBE-treated AA mice, could well have been a
consequence of an impaired recruitment (Vestergaard et al.,
2000). However, no evidence for impaired T-cell extravasa-
tion was obtained in AA mice that had been treated with a
contact allergen for three times.
LNC of untreated and allergen-treated AA mice displayed
high migratory activity in vitro even in the absence of an
external stimulus, whereas LNC from allergen-treated mice
migrated only in the presence of chemoattractants. None-
theless, the migratory activity of all groups of mice was
strengthened in the presence of chemoattractants, with
OPN being the stronger attractant than CXCL10. Although
the differences in response to OPN versus CXCL10 were only
gradual, it should be mentioned that induction of AA could
be prevented and the severity of a delayed-type hypersensi-
tivity reaction could be mitigated by application of anti-
CD44v10 (Ro¨sel et al., 1997; Freyschmidt-Paul et al., 2000).
CD44-targeting OPN (Weber et al., 1996; Katagiri et al.,
1999), the stronger effect of OPN on the migratory activity of
LNC from SADBE-treated and AA mice could be supported
by their high CD44 expression.
Importantly, intravenously applied, dye-labelled LNC
were recovered at high frequencies in skin-draining nodes
and the dermis of untreated and allergen-treated AA
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Figure 6. Unimpaired lymph node and skin homing of LNC from allergen-treated as compared to untreated AA mice. LNC from control, AA- and SADBE-
treated mice were stained with CFSE and were i.v. injected into control, AA-, SADBE-treated, and AA/SADBE mice, that were killed after 3 days. (a and b)
The percentage of dye-labelled LNC and SkIL was evaluated by flow cytometry. (a) A representative example and (b) mean values7SD of three experiments
each with pools of cells from three mice are shown. Significant differences in the percentage of labelled cells from control versus AA- and SADBE-treated
mice are indicated by an asterisk. Significant differences in dependence on the AA/SADBE host (as compared to the untreated AA or SADBE-treated host)
are indicated by s. (c–e) LNC and SkIL were stained with the indicated antibodies and counterstained with allophycocyanin-labelled secondary antibodies.
(c) An example for the recovery of dye-labelled CD4þ cells in draining lymph nodes and SkIL of control, AA-, SADBE-treated, and AA/SADBE mice is presented.
(d and e) The percentage of marker-positive SkIL as well as of dye-labelled SkIL was evaluated. The percentage (mean7SD of three experiments with
pooled cells of three mice per group) of double fluorescent (dye labelled, marker positive) SkIL in comparison to marker-positive SkIL (¼100%) is shown.
Significant differences (Wilcoxon rank-sum test) are indicated by an asterisk (control versus AA- and SADBE-treated mice) or by s (the AA/SADBE versus
the control or the AA- or the SADBE-treated host).
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mice. Thus, a higher percentage of CD4þ , CD8þ , CD11aþ ,
panCD44þ , CD54þ , and CD102þ dye-labelled LNC from
AA- or SADBE-treated than from control mice was recovered
in the skin and skin-seeking of these subpopulations was
further enhanced in allergen-treated AA mice, that is in line
with high CCL1 and CXCL10 expression in the dermis of
these mice, supporting extravasation of monocyte and acti-
vated T-cells. Thus, the chemokine milieu in the dermis of
allergen-treated AA mice obviously does not only suffice, but
strongly supports effector cell recruitment.
Allergen treatment interferes with the migration of dermal APC
into the draining node
There has been an imbalance in the relative contribution
of monocytes and DC in the skin versus the draining node
of allergen-treated compared to untreated AA mice. These
differences and the relative reduction in CCL17 and CCL20
in allergen-treated AA mice suggested that possibly leukocyte
egress from the skin may become hampered by repeated
allergen treatment of AA mice.
The hypothesis was sustained by following the traffic of
dye-labelled SkIL towards the draining node. Although in
allergen-treated control as well as in untreated and allergen-
treated AA mice a comparable percentage of SkIL migrated
towards the draining node, analysis of the subsets of
migrating leukocytes provided evidence for reduced migra-
tion of CD11bþ , CD11cþ , DC-markerþ , and CD44v10þ ,
but not of CD4þ and CD8þ SkIL from allergen-treated as
compared to untreated AA mice. As result of the suspicion
that migration particularly of the small subpopulation of APC
was impaired, migration of a s.c.-injected mixture of dye-
labelled DC and Mf was evaluated, which confirmed the
extraordinary high immigration rate of DC into the lymph
node of AA mice. However, as demonstrated most convin-
cingly by the ratio of dye-labelled LNC to SkIL, DC and Mf
migration was less pronounced in allergen-treated mice.
Thus, it was the allergen treatment that hampered the
migration of APC in AA mice. In view of the presented data,
we suggest that the chemokine milieu in the dermis of
allergen-treated mice strongly supports effector cell retention,
whereas the lower chemokine levels in AA-affected skin are
much more adapted to allow freshly activated APC to migrate
towards the draining node. The assumption is supported by
the particularly high-level CCL17 and CCL20 expression,
which become upregulated during DC activation (Sallusto
et al., 1999; Vecchi et al., 1999; Allavena et al., 2000;
Vulcano et al., 2001), in SkIL and LNC of AA mice.
We want to comment briefly on the high retention of
CCR4þ and CCR8þ dye-labelled LNC in the dermis of
allergen-treated mice. Treg express these chemokine receptors
at a high level and respond most vigorously to chemo-
kine attraction, such that mature DC preferentially attract
Treg (Iellem et al., 2001). Although it remains to be explored,
whether the retained CCR4þ and CCR8þ cells in the skin
of allergen-treated AA mice include Treg, it is tempting
to speculate that the chemokine milieu created by repeated
application of a contact allergen may well contribute to Treg
attraction, thus providing a compensation for the paucity of
Treg in autoimmune diseases (Shevach, 2004; Paust and
Cantor, 2005), including AA (Zo¨ller et al., 2002).
In summary, maintenance of a mild chronic eczema is
accompanied by an inflammatory chemokine milieu that
strongly supports monocyte and T-cell extravasation. It is
possible, though not yet proven, that chemokine attraction
includes Treg, which could support hair regrowth in AA-
affected individuals (McElwee et al., 2005). However, the
high level of inflammatory chemokines in the dermis of
allergen-treated mice obviously hampers the migratory
activity of skin-derived APC in AA mice, which could well
contribute to a gradual reduction in AA effector cell stimu-
lation, thus allowing hair follicles to recover. Whether the
allergen-induced chemokine milieu may be beneficial not
only in AA, but also in other skin-related autoimmune
diseases, remains to be explored.
MATERIALS AND METHODS
Mice and treatment
C3H/HeJ mice, obtained from The Jackson Laboratory, Bar Harbor,
Maine, USA, received autoclaved food pellets and acidified water ad
libitum.
In vivo skin labelling
Untreated AA SADBE-treated AA/SADBE
Sk
IL
0
5
10
15
20
25
30
35
40
45
SkIL dr.LNC
%
 d
ye
-la
be
lle
d 
ce
lls
Control
AA
SADBE-treated
AA/SADBE-treated
* *
*
*
*
*
100
FL1-H
101 102 103 104 100
FL1-H
101 102 103 104 100
FL1-H
101 102 103 104 100
FL1-H
101 102 103 104
LN
C
a b
Figure 7. Leukocyte migration from the skin towards the draining lymph node in untreated and allergen-treated AA mice. FITC (250mg/mouse) was dissolved
in ethanol and was gently rubbered into the shaved skin. Mice were sacrificed after 3 days. (a and b) The percentage of fluorescent cells was evaluated in
SkIL and draining lymph nodes. (a) A representative example and (b) the percentage of fluorescent cells (mean7SD of three experiments with pools of cells
of three mice per group) is shown. Significant differences in the percentage of stained draining LNC between control, AA-, SADBE-treated, and AA/SADBE
mice are indicated by an asterisk.
1568 Journal of Investigative Dermatology (2006), Volume 126
P Gupta et al.
Leukocyte Migration in Alopecia Areata
AA was induced by the transfer of full-thickness skin graft from
spontaneously AA-affected female mice to female, normal haired
mice (McElwee et al., 1998). Grafted mice (90%) develop AA within
6 weeks after skin transplantation. Where indicated, mice were
treated with SADBE (Freyschmidt-Paul et al., 1999). Mice were
sensitized on a 1.0 1.0 cm2 area of the back with 2% SADBE in
acetone, followed by weekly topical applications of 0.5 or 1%
SADBE in acetone on both sides of the back, such that a moderately
severe contact dermatitis, lasting for 2–3 days, was induced.
Complete hair regrowth is observed after 8–12 weeks. According
to a detailed time schedule analysis, all mice were challenged for
three times, that is in AA-affected mice the process of hair regrowth
was still ongoing, and were killed 3 days after the 3rd challenge.
Animal experimentations were approved by the local governmental
authorities.
Tissue preparation
Mice were killed by cervical dislocation. Skin and draining lymph
nodes were collected. Dorsal skin samples were embedded in
OCT compound (Tissue Tek, Sakura, Zoeterwoude, Netherlands)
and snap frozen in liquid nitrogen. For the isolation of SkIL, skin was
layered epidermis uppermost on sterile gauze and incubated three
times 30 minutes with a 1 mg/ml trypsin/EDTA solution collecting
the isolated cells in RPMI containing 10% fetal calf serum (RPMI-
fetal calf serum) after each incubation. After the final trypsin
treatment, pooled cells were washed and incubated for 2 hours at
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Figure 8. Impaired migration of FITC-labelled leukocyte subpopulations from the skin to draining lymph nodes of allergen-treated AA mice. Mice
were treated as described in Figure 7. (a and e) Draining LNC and SkIL of control, AA-, SADBE-treated, and AA/SADBE mice were stained with antibodies
for the indicated markers, where cells had been fixed and permeabilized in advance for chemokine staining. Cells were counterstained with the
allophycocyanin-labelled secondary antibodies. Representative examples are shown. (b, c, f, and g) The percentage of FITC-labelled, marker expressing LNC
and SkIL was evaluated as described in Figure 6, i.e. the percentage of FITC-labelled, marker-positive cells in comparison to marker-positive cells (¼100%)
is presented. In (d and h) the relative contribution of FITC-labelled, marker-positive cells in the draining lymph node and the skin are presented as the ratio
of marker-positive, FITC-labelled LNC: marker-positive, FITC-labelled SkIL (mean7SD of three experiments with pools of cells from three mice per group).
Significant differences in the percentage of double-stained draining LNC and SkIL (b, c, f, and g) between control, AA-, SADBE-treated, and AA/SADBE mice
(Student’s t-test), and (d and h) significance of differences in the ratio of double-labelled LNC versus SkIL (Wilcoxon rank-sum test) are indicated by an asterisk.
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371C, 5% CO2 in RPMI-fetal calf serum plus 10
3
M N-[2-
hydroxyethyl]piperazine-N0-[2-ethanesulphonic acid] buffer to
allow for the recovery of surface molecule expression. Single cell
suspensions from skin-draining nodes were prepared by pressing
through fine gauze. CD11cþ LNC were enriched using anti-CD11c
(clone N418) MACS (Miltenyi, Bergisch, Gladbach, Germany).
Monocytes were separated by seeding on Petri dishes particularly
suited for the recovery of adherent cells (Corning Incorp., New York,
NY). After 2 1 hour incubation at 371C, non-adherent cells were
vigorously washed off and the adherent cells were recovered with a
rubber policemen. Flow cytrometry revealed over 90% of the
recovered cells to be CD11bþ . Viability, as determined by trypan
blue exclusion, was in the range of 70–75% for SkIL, 95–98% for
LNC and CD11cþ cells and 80–90% for CD11bþ cells.
Antibodies
The following primary anti-mouse antibodies were used: anti-CD4
(YTA3.2.1), -CD8 (YTS169.4.2.1), -CD11a (M17.5.2), -CD11b
(YBM6.6.10), -CD54 (YN1/1.7.4) (European Animal Cell Culture
Collection, Porton Down, UK), -CD25 (7D4), -panCD44 (IM7), -DC
(33D1) (American Type Culture Collection, Manassas, VA),
-CD44v10 (K926) (Ro¨sel et al., 1997), -CD49d (PS/2) (Hession
et al., 1992), -CD11c (HL3), -CD16/32 (DX5), -CD51 (H9.2.B8),
-CD61 (2C9.G2), -CD102 (3C4), -CD103 (M290), -CD105 (MJ7/18),
-CD106 (429), IL4 (BVD6-24G2), IL6 (MP5-32C11), -IL10 (JES3-
16E3), -IL12 (C17.8), -IFNg (XMG1.2), -TNFa (MP6-XT3), -CCL2 (2H5)
(BD/Pharmingen, Heidelberg, Germany), -CCL1, -CCL17, -CCL20,
-CCR6 (R&D, Wiesbaden, Germany), -CCL5, -CCL3 (Biotrend, Ko¨ln,
Germany), - OPN (Assay Designs, Ann Arbor, MI), -CCR4, -CCR8
(Abcam LtD, Cambridgeshire, UK). Secondary reagents were FITC-,
PE-, or allophycocyanin-labelled anti-rat IgG, anti-rat IgM, anti-rabbit
IgG, anti-hamster IgG, or Streptavidin (Strep) (Dianova, Hamburg, or
BD, Heidelberg, or Biotrend, Ko¨ln, Germany).
Flow cytometry
Cells (1–3 105) were stained according to routine procedures. For
intracellular staining of cytokines and chemokines, cells were fixed
and permeabilized in advance. As far as mice had received CFSE-
labelled cells or topical application of FITC, secondary antibodies
were allophycocyanin-labelled. Staining was evaluated using a
FACS-Calibur (Becton Dickinson, Heidelberg, Germany) excluding
contaminating keratinocytes in SkIL preparation and cell debris
by gating. Analysis was performed by the Cell Quest program. All
experiments were repeated at least three times.
Cell transfer and migration
Single LNC suspensions from pooled skin draining lymph nodes or a
1:1 mixture of CD11cþ and CD11bþ cells were labelled with CFSE.
Mice received (1 107) leukocytes i.v. or s.c. In the latter case, the
dye-labelled leukocytes were applied in six aliquots distributed over
the dorsal skin. Alternatively, shaved mice were treated with FITC in
acetone, such that a total amount of 250 mg was equally distributed
over the dorsal skin. Mice were killed after 3 days.
In vitro leukocyte migration
Draining LNC (5 104) were seeded in the upper part of a Boyden
chamber in 30 ml RPMI/0.1% bovine serum albumin. The lower
part of the chamber, separated by a 5 mm pore size polycarbonate
membrane (Neuroprobe, Gaithersburg, MD) contained 30 ml RPMI/
0.1% bovine serum albumin or 0.1% bovine serum albumin plus
40 ng/ml OPN (R&D, Wiesbaden, Germany) or 4 ng/ml CXCL10
(Biotrend, Ko¨ln, Germany). After 4 hours incubation, cells in the
lower chamber were counted. Assays were carried out in triplicates.
Cell migration is presented as percent migrating cells taking the
starting load as 100%.
Immunohistology
Sections (5 mm) of snap-frozen skin were fixed in chloroform/acetone
(1:1) for 4 minutes and were treated with levamisole solution to
0
1
2
R
at
io
 d
ye
-la
be
lle
d 
LN
C 
: S
kI
L
0
10
20
30
40
50
%
 d
ye
-la
be
lle
d 
m
ar
ke
r+
Sk
IL
ss
s
*
*
*
*
*
*
*
Subcutaneous transfer of dye-labelled DC plus M
c
a
s
s
0
10
20
30
40
CD11b CD44v10 CD11c
CD11b CD44v10 CD11c
CD11b CD44v10 CD11c
%
 d
ye
-la
be
lle
d 
m
ar
ke
r+
dr
.L
NC AA-->AAAA-->AA/SADBE
SADBE-->SADBE
SADBE-->AA/SADBE
AA-->AA
AA-->AA/SADBE
SADBE-->SADBE
SADBE-->AA/SADBE
AA-->AA
AA-->AA/SADBE
SADBE-->SADBE
SADBE-->AA/SADBE
b
Figure 9. Reduced DC migration from the skin towards the draining lymph
node in allergen-treated mice. CD11cþ and CD11bþ LNC were separated
from AA- and SADBE-treated mice as described in Materials and Methods.
Cells were mixed at a 1:1 ratio, were labelled with CFSE and were s.c.
injected at eight different sites under the dorsal skin of AA-, SADBE-treated,
and AA/SADBE mice. Mice were killed after 3 days. Draining LNC
and SkIL were stained with antibodies for the indicated markers and
allophycocyanin-labelled secondary antibodies. The percentage of
dye-labelled, (a) marker-positive LNC and (b) SkIL in comparison to marker
positive cells was evaluated as described in Figure 6. In (c) the ratio of
double-labelled LNC versus SkIL is presented. Significant differences (mean7
SD from three separate experiments with pools of cells from two to three
mice per group) between AA- and SADBE-treated mice are indicated by an
asterisk; significant differences between the AA/SADBE host, that received
CD11cþ and CD11bþ cells from AA- or SADBE-treated mice, as compared
to the AA- or SADBE-treated host are indicated by s. Significant differences
in the ratio of double-labelled LNC versus (c) was calculated by the
Wilcoxon rank-sum test.
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ablate tissue alkaline phosphatase activity. Non-specific binding was
blocked using an avidin-biotin blocking kit (Vector Laboratories,
Burlingame, CA) and 2% normal serum derived from the same
species as the secondary antibodies. For chemokine staining, tissues
were fixed in paraformaldehyde (4%) and were permeabilized
with 0.1% Triton X-100 (4 minutes, 41C). Tissues were incubated
for 1 hour with the primary antibody, washed and exposed
to biotinylated secondary antibodies (30 minutes) and alkaline
phosphatase conjugated avidin–biotin complex solutions (5–20
minutes). Sections were counter-stained with Mayer’s Hematoxylin.
The primary antibody was replaced with normal rat or rabbit IgG for
negative controls.
Statistics
Significance was evaluated by the two-tailed Student’s t-test for
unequal variance with P-values adjusted for multiple comparisons
by the step-down Bonferoni method of Holm or by the Wilcoxon
rank-sum test. P-values o0.5 (Student’s t-test) and the minimal
possible P-value of 0.1 (Wilcoxon rank-sum test) were considered
significant.
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